v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities    
Net loss $ (158,349) $ (168,385)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation expense 20,720 51,767
Depreciation and amortization expense 416 416
Accretion of premium and discounts on marketable securities (4,944) (11,821)
Income tax benefit (6,356) 0
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (1,527) 5,914
Other assets (2,939) 0
Accounts payable 8,487 206
Accrued expenses and other liabilities 12,651 (13,421)
Operating lease liabilities (190) (175)
Net cash used in operating activities (132,031) (135,499)
Cash flows from investing activities    
Purchases of marketable securities (281,939) (461,177)
Sales and maturities of marketable securities 470,732 517,282
Net cash provided by investing activities 188,793 56,105
Cash flows from financing activities    
Proceeds from issuance of common stock under ESPP 201 267
Proceeds from issuance of common stock upon option exercise 58 0
Stock repurchase (25,519) 0
Cash paid for taxes in connection with RSU and PSU vesting (485) 0
Net cash (used in) provided by financing activities (25,745) 267
Net increase (decrease) in cash and cash equivalents 31,017 (79,127)
Cash and cash equivalents at the beginning of period 64,696 143,823
Total cash and cash equivalents $ 95,713 $ 64,696